We take your privacy very seriously, please consent to the use of all cookies when visiting our website. for more information on the processing of personal data, please refer to the Privacy Policy.

First in China! HeYou Zhizhen Hospital Approved for Canakinumab, Adding a New Drug to the "Hong Kong and Macau Drug and Device Connect" Initiative, Providing a "Precision Anti-Inflammatory" Solution for Acute Gout and Autoinflammatory Diseases

  • News
  • 2026-05-06